Page last updated: 2024-09-03

mk 0663 and Acute Disease

mk 0663 has been researched along with Acute Disease in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (78.57)29.6817
2010's3 (21.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kokalj, A; Maquirriain, J1
Liu, P; Ma, JL; Wang, J; Zhang, S; Zhang, W; Zhang, Y1
Norquist, JM; Schlesinger, N; Watson, DJ1
Fokter, SK; Repse-Fokter, A1
Chang, DJ; Desjardins, PJ; Erb, T; Geba, GP; King, TR1
Ang, J; Fricke, JR; Malmstrom, K; Reicin, A; Shingo, S1
Krüger, K1
Andersen, ML; Schütz, TC; Tufik, S1
Navarra, S; Rubin, BR; Smugar, SS; Tershakovec, AM; Yu, Q1
Abdalla, GK; Castro, EC; Faria, GE; Michelin, MA; Reis, MA; Silva, KT1
Murphy, E; O'Connor, MB; Phelan, MJ; Regan, MJ1
Lammintausta, K; Mäkelä, L1
Boice, JA; Daikh, DI; Malmstrom, K; Molina, J; Mukhopadhyay, S; Ng, J; Schumacher, HR; Tate, GA1

Reviews

2 review(s) available for mk 0663 and Acute Disease

ArticleYear
Efficacy and safety of etoricoxib compared with NSAIDs in acute gout: a systematic review and a meta-analysis.
    Clinical rheumatology, 2016, Volume: 35, Issue:1

    Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Gout; Humans; Indomethacin; Pain Measurement; Pyridines; Randomized Controlled Trials as Topic; Sulfones; Treatment Outcome

2016
[The efficacy of selective Cox-2-inhibitors in comparison with conventional NSAIDs].
    MMW Fortschritte der Medizin, 2005, Aug-04, Volume: 147, Issue:31-32

    Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Celecoxib; Controlled Clinical Trials as Topic; Cyclooxygenase Inhibitors; Etoricoxib; Gout; Humans; Osteoarthritis; Placebos; Pyrazoles; Pyridines; Rheumatic Diseases; Spondylitis, Ankylosing; Sulfonamides; Sulfones

2005

Trials

6 trial(s) available for mk 0663 and Acute Disease

ArticleYear
Management of acute Achilles tendinopathy: effect of etoricoxib on pain control and leg stiffness.
    Georgian medical news, 2013, Issue:222

    Topics: Achilles Tendon; Acute Disease; Administration, Oral; Adolescent; Adult; Athletic Injuries; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Etoricoxib; Humans; Leg; Male; Middle Aged; Pain Management; Pain Measurement; Pyridines; Sulfones; Tendinopathy; Treatment Outcome; Young Adult

2013
Serum urate during acute gout.
    The Journal of rheumatology, 2009, Volume: 36, Issue:6

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Cyclooxygenase Inhibitors; Etoricoxib; Female; Gout; Gout Suppressants; Humans; Indomethacin; Male; Middle Aged; Pyridines; Sulfones; Treatment Outcome; Uric Acid; Young Adult

2009
The analgesic efficacy of etoricoxib compared with oxycodone/acetaminophen in an acute postoperative pain model: a randomized, double-blind clinical trial.
    Anesthesia and analgesia, 2004, Volume: 99, Issue:3

    Topics: Acetaminophen; Acute Disease; Adult; Double-Blind Method; Drug Therapy, Combination; Etoricoxib; Female; Humans; Male; Oxycodone; Pain, Postoperative; Pyridines; Sulfones

2004
The analgesic effect of etoricoxib relative to that of cetaminophen analgesics: a randomized, controlled single-dose study in acute dental impaction pain.
    Current medical research and opinion, 2005, Volume: 21, Issue:1

    Topics: Acetaminophen; Acute Disease; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Analysis of Variance; Codeine; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Combinations; Etoricoxib; Female; Humans; Male; Oxycodone; Pain; Pain Measurement; Proportional Hazards Models; Pyridines; Sulfones; Tooth, Impacted; Treatment Outcome

2005
Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout.
    Current medical research and opinion, 2007, Volume: 23, Issue:7

    Topics: Acute Disease; Adult; Arthralgia; Arthritis; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Resistance; Etoricoxib; Female; Gout; Gout Suppressants; Humans; Indomethacin; Male; Middle Aged; Pyridines; Sulfones

2007
Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis.
    BMJ (Clinical research ed.), 2002, Jun-22, Volume: 324, Issue:7352

    Topics: Acute Disease; Adult; Aged; Arthritis, Gouty; Cyclooxygenase Inhibitors; Double-Blind Method; Etoricoxib; Female; Gout Suppressants; Humans; Indomethacin; Male; Middle Aged; Pain; Pain Measurement; Pyridines; Sulfones; Treatment Outcome

2002

Other Studies

6 other study(ies) available for mk 0663 and Acute Disease

ArticleYear
Acute gouty arthritis in a patient after total knee arthroplasty.
    Wiener klinische Wochenschrift, 2010, Volume: 122, Issue:11-12

    Topics: Acute Disease; Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Arthroplasty, Replacement, Knee; Diagnosis, Differential; Drug Therapy, Combination; Etoricoxib; Follow-Up Studies; Gout Suppressants; Humans; Male; Osteoarthritis, Knee; Postoperative Complications; Pyridines; Sulfones

2010
[Rapidly acting and powerful antirheumatic drug now also approved in Germany. Arcoxia (etoricoxib, MSD)]].
    Krankenpflege Journal, 2004, Volume: 42, Issue:7-10

    Topics: Acute Disease; Antirheumatic Agents; Arthralgia; Arthritis, Rheumatoid; Clinical Trials as Topic; Drug Approval; Etoricoxib; Gout; Humans; Indomethacin; Osteoarthritis; Pain Measurement; Pyridines; Sulfones

2004
Effects of COX-2 inhibitor in temporomandibular joint acute inflammation.
    Journal of dental research, 2007, Volume: 86, Issue:5

    Topics: Acute Disease; Animals; Arthritis, Experimental; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Etoricoxib; Male; Prostaglandin D2; Pyridines; Random Allocation; Rats; Rats, Wistar; Sleep Wake Disorders; Sleep, REM; Sulfones; Temporomandibular Joint Disorders

2007
Trypanosoma cruzi: the role of PGE2 in immune response during the acute phase of experimental infection.
    Experimental parasitology, 2008, Volume: 118, Issue:4

    Topics: Acute Disease; Animals; Cells, Cultured; Chagas Disease; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Etoricoxib; Fibrosis; Male; Meloxicam; Mice; Mice, Inbred BALB C; Myocardium; Parasitemia; Prostaglandins; Pyridines; Spleen; Sulfones; Thiazines; Thiazoles; Trypanosoma cruzi

2008
Primary stabbing headache can be responsive to etoricoxib, a selective COX-2 inhibitor.
    European journal of neurology, 2008, Volume: 15, Issue:1

    Topics: Acute Disease; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Etoricoxib; Female; Headache Disorders, Primary; Humans; Indomethacin; Ophthalmic Nerve; Pain, Intractable; Pyridines; Sulfones; Treatment Outcome

2008
Etoricoxib-induced acute generalized exanthematous pustulosis.
    Acta dermato-venereologica, 2008, Volume: 88, Issue:2

    Topics: Acute Disease; Cyclooxygenase 2 Inhibitors; Drug Eruptions; Drug Hypersensitivity; Etoricoxib; Exanthema; Humans; Male; Middle Aged; Patch Tests; Pyridines; Skin; Skin Diseases, Vesiculobullous; Sulfones

2008